338 related articles for article (PubMed ID: 23744764)
21. Analysis of the 5-lipoxygenase promoter and characterization of a vitamin D receptor binding site.
Sorg BL; Klan N; Seuter S; Dishart D; Rådmark O; Habenicht A; Carlberg C; Werz O; Steinhilber D
Biochim Biophys Acta; 2006 Jul; 1761(7):686-97. PubMed ID: 16750418
[TBL] [Abstract][Full Text] [Related]
22. The impact of chromatin organization of vitamin D target genes.
Carlberg C; Dunlop TW
Anticancer Res; 2006; 26(4A):2637-45. PubMed ID: 16886674
[TBL] [Abstract][Full Text] [Related]
23. Identification of the functional vitamin D response elements in the human MDR1 gene.
Saeki M; Kurose K; Tohkin M; Hasegawa R
Biochem Pharmacol; 2008 Aug; 76(4):531-42. PubMed ID: 18602086
[TBL] [Abstract][Full Text] [Related]
24. Interaction of two novel 14-epivitamin D3 analogs with vitamin D3 receptor-retinoid X receptor heterodimers on vitamin D3 responsive elements.
Verlinden L; Verstuyf A; Quack M; Van Camp M; Van Etten E; De Clercq P; Vandewalle M; Carlberg C; Bouillon R
J Bone Miner Res; 2001 Apr; 16(4):625-38. PubMed ID: 11315990
[TBL] [Abstract][Full Text] [Related]
25. DNA sequences in the rat parathyroid hormone-related peptide gene responsible for 1,25-dihydroxyvitamin D3-mediated transcriptional repression.
Falzon M
Mol Endocrinol; 1996 Jun; 10(6):672-81. PubMed ID: 8776727
[TBL] [Abstract][Full Text] [Related]
26. The vitamin D receptor represses transcription of the pituitary transcription factor Pit-1 gene without involvement of the retinoid X receptor.
Seoane S; Perez-Fernandez R
Mol Endocrinol; 2006 Apr; 20(4):735-48. PubMed ID: 16322098
[TBL] [Abstract][Full Text] [Related]
27. Transrepression by a liganded nuclear receptor via a bHLH activator through co-regulator switching.
Murayama A; Kim MS; Yanagisawa J; Takeyama K; Kato S
EMBO J; 2004 Apr; 23(7):1598-608. PubMed ID: 15934135
[TBL] [Abstract][Full Text] [Related]
28. The vitamin D hormone and its nuclear receptor: molecular actions and disease states.
Haussler MR; Haussler CA; Jurutka PW; Thompson PD; Hsieh JC; Remus LS; Selznick SH; Whitfield GK
J Endocrinol; 1997 Sep; 154 Suppl():S57-73. PubMed ID: 9379138
[TBL] [Abstract][Full Text] [Related]
29. SIRT1 enzymatically potentiates 1,25-dihydroxyvitamin D
Sabir MS; Khan Z; Hu C; Galligan MA; Dussik CM; Mallick S; Stone AD; Batie SF; Jacobs ET; Whitfield GK; Haussler MR; Heck MC; Jurutka PW
J Steroid Biochem Mol Biol; 2017 Sep; 172():117-129. PubMed ID: 28636886
[TBL] [Abstract][Full Text] [Related]
30. Negative regulation of human parathyroid hormone gene promoter by vitamin D3 through nuclear factor Y.
Jääskeläinen T; Huhtakangas J; Mäenpää PH
Biochem Biophys Res Commun; 2005 Mar; 328(4):831-7. PubMed ID: 15707954
[TBL] [Abstract][Full Text] [Related]
31. Vitamin D-dependent recruitment of DNA-PK to the chromatinized negative vitamin D response element in the PTHrP gene is required for gene repression by vitamin D.
Okazaki T; Nishimori S; Ogata E; Fujita T
Biochem Biophys Res Commun; 2003 May; 304(4):632-7. PubMed ID: 12727200
[TBL] [Abstract][Full Text] [Related]
32. 1alpha,25-Dihydroxyvitamin D3 down-regulates estrogen receptor abundance and suppresses estrogen actions in MCF-7 human breast cancer cells.
Swami S; Krishnan AV; Feldman D
Clin Cancer Res; 2000 Aug; 6(8):3371-9. PubMed ID: 10955825
[TBL] [Abstract][Full Text] [Related]
33. 1,25-Dihydroxyvitamin D3 regulates the expression of low-density lipoprotein receptor-related protein 5 via deoxyribonucleic acid sequence elements located downstream of the start site of transcription.
Fretz JA; Zella LA; Kim S; Shevde NK; Pike JW
Mol Endocrinol; 2006 Sep; 20(9):2215-30. PubMed ID: 16613987
[TBL] [Abstract][Full Text] [Related]
34. Modulation of vitamin D receptor and estrogen receptor by 1,25(OH)2-vitamin D3 in T-47D human breast cancer cells.
Davoodi F; Brenner RV; Evans SR; Schumaker LM; Shabahang M; Nauta RJ; Buras RR
J Steroid Biochem Mol Biol; 1995 Aug; 54(3-4):147-53. PubMed ID: 7662588
[TBL] [Abstract][Full Text] [Related]
35. 1,25-Dihydroxyvitamin D3 up-regulates expression of hsa-let-7a-2 through the interaction of VDR/VDRE in human lung cancer A549 cells.
Guan H; Liu C; Chen Z; Wang L; Li C; Zhao J; Yu Y; Zhang P; Chen W; Jiang A
Gene; 2013 Jun; 522(2):142-6. PubMed ID: 23566834
[TBL] [Abstract][Full Text] [Related]
36. Vitamin D receptor displays DNA binding and transactivation as a heterodimer with the retinoid X receptor, but not with the thyroid hormone receptor.
Thompson PD; Hsieh JC; Whitfield GK; Haussler CA; Jurutka PW; Galligan MA; Tillman JB; Spindler SR; Haussler MR
J Cell Biochem; 1999 Dec; 75(3):462-80. PubMed ID: 10536369
[TBL] [Abstract][Full Text] [Related]
37. The potential therapeutic benefits of vitamin D in the treatment of estrogen receptor positive breast cancer.
Krishnan AV; Swami S; Feldman D
Steroids; 2012 Sep; 77(11):1107-12. PubMed ID: 22801352
[TBL] [Abstract][Full Text] [Related]
38. Analysis of regulatory regions in the COL1A1 gene responsible for 1,25-dihydroxyvitamin D3-mediated transcriptional repression in osteoblastic cells.
Pavlin D; Bedalov A; Kronenberg MS; Kream BE; Rowe DW; Smith CL; Pike JW; Lichtler AC
J Cell Biochem; 1994 Dec; 56(4):490-501. PubMed ID: 7890807
[TBL] [Abstract][Full Text] [Related]
39. Inhibition of apolipoprotein AI gene expression by 1, 25-dihydroxyvitamin D3.
Wehmeier K; Beers A; Haas MJ; Wong NC; Steinmeyer A; Zugel U; Mooradian AD
Biochim Biophys Acta; 2005 Oct; 1737(1):16-26. PubMed ID: 16236546
[TBL] [Abstract][Full Text] [Related]
40. Transactivation of rat apical sodium-dependent bile acid transporter and increased bile acid transport by 1alpha,25-dihydroxyvitamin D3 via the vitamin D receptor.
Chen X; Chen F; Liu S; Glaeser H; Dawson PA; Hofmann AF; Kim RB; Shneider BL; Pang KS
Mol Pharmacol; 2006 Jun; 69(6):1913-23. PubMed ID: 16481392
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
